Breaking News

NAMSA Expands in Europe

March 14, 2012

Research organization and testing firm opens office in Germany.

NAMSA, the Northwood, Ohio-based medical device research organization, has said guten tag to Germany. The company has opened its newest office near Frankfurt. Staff with regulatory and quality expertise, clinical managers and local monitors will provide support for European clinical trials as well as European device makers seeking approvals in the United States, according to the company.

This isn’t, however, the firms first foray into Europe. NAMSA’s testing laboratory near Lyon, France, has been conducting non-clinical safety and efficacy studies for medical device companies since 1986.

“U.S. companies can have confidence that the high quality support they’ve valued in NAMSA’s U.S. clinical and consulting operations are now available in Europe, ensuring the same responsiveness and thoroughness on both sides of ‘the pond,’” said Elizabeth Kempen, chief operating officer of NAMSA's clinical research and consulting groups.

European market approval has emerged as a preferred pathway for medical device manufacturers primarily due to more efficient approval processes, Kempen claimed.

“The placement of this office reinforces NAMSA’s commitment to helping our clients design and execute global regulatory and clinical strategies, develop new therapies, and launch them in the most efficient manner possible,” said John Gorski, NAMSA’s president and CEO. “The combination of non-clinical and clinical research expertise at our European locations enables NAMSA to provide our clients with a higher level of continuity, consistency and convenience throughout the product development process.”

NAMSA provides range of services to prove efficacy, non-clinical and clinical safety of medical devices, IVDs and combination products.

Related Manufacturing Processes:

  • An FAQ on Adaptive Design for Device Trials

    An FAQ on Adaptive Design for Device Trials

    Vicki Anastasi, Vice President and Global Head, Medical Devices & Diagnostics Research, ICON plc||November 9, 2016
    This “Ask the Experts” style article provides insights regarding common questions posed about this trial strategy.

  • 3 Tips to Reduce the Chance of a 510(k) Submission Rejection

    3 Tips to Reduce the Chance of a 510(k) Submission Rejection

    Jesseca Lyons, Customer Success Expert, greenlight.guru||September 15, 2016
    Don’t let all of your effort seem like a waste with an unfavorable response from the FDA.

  • 5 Considerations for Human Factors Testing

    5 Considerations for Human Factors Testing

    Kady Harper, Technical Writer||September 13, 2016
    When developing a device, the way it will be used, who uses it, and where it’s used are all critical factors to consider.